You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Homologous recombination DNA repair defects

Showing 1 - 25 of 9,718
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Testing Circulating Tumour DNA for Homologous Recombination Gene

Recruiting
  • Circulating Tumor DNA
  • Metastatic Prostate Cancer
  • Blood sample
  • Urine sample
  • Tours, France
    University hospital
Sep 6, 2022

Homologous Recombination Repair Pathway Gene Mutation Spectrum

Not yet recruiting
  • Breast Cancer
    • (no location specified)
    Jun 4, 2023

    Cancer Trial in Melbourne (Pamiparib, Tislelizumab)

    Recruiting
    • Cancer
    • Melbourne, Victoria, Australia
      Peter MacCallum Cancer Centre
    Mar 3, 2022

    Solid Tumor, Adult Trial in Miami (Pembrolizumab 200 mg Q3W)

    Active, not recruiting
    • Solid Tumor, Adult
    • Pembrolizumab 200 mg Q3W
    • Miami, Florida
      Miami Cancer Institute at Baptist Health, Inc.
    Nov 18, 2022

    Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer

    Recruiting
    • Lung Cancer
      • Shanghai, China
        Shanghai Chest Hospital
      Jul 20, 2023

      HRD and Resistance to PAPPi in EOC Patients

      Recruiting
      • Epithelial Ovarian Cancer
      • +6 more
      • Testing of homologous recombination deficiency
      • Beijing, Beijing, China
        Lei Li
      Mar 26, 2022

      Hyperthermic Intraperitoneal Chemotherapy to Ovarian Cancer

      Not yet recruiting
      • Ovarian Cancer
      • HIPEC
      • (no location specified)
      Mar 2, 2022

      mCRPC Trial in Australia, China, United States (Placebo, Senaparib)

      Not yet recruiting
      • mCRPC
      • Binghamton, New York
      • +5 more
      Dec 14, 2021

      Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Retroperitoneal Sarcoma AJCC v8 Trial in Columbus

      Not yet recruiting
      • Locally Advanced Leiomyosarcoma
      • +6 more
      • Niraparib Tosylate Monohydrate
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Jul 25, 2022

      ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer, a Germline or Somatic BRCA Mutation, or a

      Recruiting
      • ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer
      • a Germline or Somatic BRCA Mutation, or a Deleterious Alteration of Other Genes Involved in Homologous Recombination Repair (HRR) or in MSI Status
      • Montpellier, France
      • +1 more
      Nov 16, 2022

      Advanced Cancers Trial in Boston (LY2606368)

      Active, not recruiting
      Has Results
      • Advanced Cancers
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      Jan 18, 2022

      Locally Recurrent/Metastatic Triple Negative Breast Cancer Trial in United States (radiation, drug, procedure)

      Recruiting
      • Locally Recurrent/Metastatic Triple Negative Breast Cancer
      • external beam radiation therapy
      • +2 more
      • Basking Ridge, New Jersey
      • +6 more
      Aug 8, 2022

      HRR Prevalence in LatAm PROSPECT Study

      Completed
      • Castration-resistant Prostate Cancer
        • Ciudad Autónoma de Buenos Aires, Argentina
        • +10 more
        Apr 19, 2022

        Castration Resistant Prostatic Cancer, Metastatic Prostate Cancer Trial in San Francisco (Pembrolizumab, Chemotherapy)

        Active, not recruiting
        • Castration Resistant Prostatic Cancer
        • Metastatic Prostate Cancer
        • San Francisco, California
          University of California, San Francisco
        May 17, 2022

        ATM Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Sacramento (Niraparib, Niraparib Tosylate Monohydrate,

        Recruiting
        • ATM Gene Mutation
        • +16 more
        • Sacramento, California
          University of California Davis Comprehensive Cancer Center
        Oct 27, 2022

        Prostate Adenocarcinoma Trial in Philadelphia (Niraparib Pill)

        Recruiting
        • Prostate Adenocarcinoma
        • Niraparib Pill
        • Philadelphia, Pennsylvania
          Abramson Cancer Center of the University of Pennsylvania
        Mar 29, 2022

        Immunotherapy Trial in France (olaparib, durvalumab, tremelimumab)

        Recruiting
        • Immunotherapy
        • olaparib, durvalumab, tremelimumab
        • Amiens, France
        • +7 more
        May 21, 2021

        Prostate Cancer, Adenocarcinoma of the Prostate Trial in Providence (Olaparib Pill, Prostatectomy)

        Terminated
        Has Results
        • Prostate Cancer
        • Adenocarcinoma of the Prostate
        • Olaparib Pill
        • Prostatectomy
        • Providence, Rhode Island
          Lifespan Cancer Institute: The Miriam and Rhode Island Hospitals
        Feb 2, 2022

        Prostate Cancer Trial in Porto Alegre, Sao Paulo (Nivolumab)

        Active, not recruiting
        • Prostate Cancer
        • Porto Alegre, Rio Grande Do Sul, Brazil
        • +1 more
        Aug 24, 2021

        Pathogenic Variants in Homologous Recombination Repair Genes in

        Completed
        • Epithelial Ovarian Cancer
        • Tumor molecular profiling
        • (no location specified)
        Jan 18, 2021

        HER2-negative Breast Cancer, Gastric Adenocarcinoma, Cholangiocarcinoma Trial in Beijing (Niraparib, Anlotinib)

        Not yet recruiting
        • HER2-negative Breast Cancer
        • +3 more
        • Beijing, Beijing, China
          Beijing Cancer Hospital
        Feb 18, 2021

        Breast Cancer Trial in Marseille (M1774, Fulvestrant injection)

        Not yet recruiting
        • Breast Cancer
        • Marseille, France
          Institut Paoli Calmettes
        Aug 9, 2023

        Advanced Solid Tumors Trial in Worldwide (Olaparib)

        Recruiting
        • Advanced Solid Neoplasms
        • Tucson, Arizona
        • +128 more
        Aug 18, 2022

        Solid Tumors, Homologous Recombination Repair Gene Mutation, Homologous Recombination Deficiency Trial in Korea, Republic of

        Recruiting
        • Solid Tumors
        • +2 more
        • Goyang, Gyeongggi-do, Korea, Republic of
        • +17 more
        Jan 20, 2022

        Metastatic Melanoma Trial in San Francisco (Niraparib)

        Recruiting
        • Metastatic Melanoma
        • San Francisco, California
          California Pacific Medical Center Research Institute
        Oct 15, 2021